What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?
Petrini P. Petrini P.
. Alzheimers Dement (N Y). 2017 Nov 7;3(4):603-611. doi: 10.1016/j.trci.2017.09.002. eCollection 2017 Nov. Alzheimers Dement (N Y). 2017. PMID: 29201994 Free PMC article.
.
Item in Clipboard
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
